Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Interferon-α induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo

Abstract

The ability of interferon-α (IFN-α) to induce dendritic cell (DC) differentiation in chronic myeloid leukemia (CML) was evaluated. Peripheral blood mononuclear cells from CML patients cultured with IFN-α and granulocyte–macrophage colony-stimulating factor (GM-CSF) developed a dendritic morphology. Fluorescence in situ hybridization demonstrated that the DCs harbored the bcr/abl translocation. The DCs prepared with IFN-α/GM-CSF expressed significantly higher levels of class I and II HLA than those grown in interleukin-4 (IL-4) and GM-CSF. The DCs prepared from newly diagnosed CML patients using IFN-α/GM-CSF expressed immunoregulatory proteins at levels comparable to normal DCs. In contrast, DCs cultured from CML patients who did not achieve a cytogenetic response to IFN-α expressed significantly lower levels of class I HLA, CD40, CD54, CD80 and CD86 than normal DCs. The expression of CD86 by CML DCs was enhanced when they were cultured with IFN-α/IL-4/GM-CSF, or when IFN-α/GM-CSF-treated cells were induced to mature by CD40 ligand. The DCs from IFN-α failures were less stimulatory than normal DCs in the allogeneic mixed leukocyte reaction. CML patients who had a cytogenetic response to IFN-α initially had low numbers of bone marrow DCs that increased significantly with treatment, while nonresponders had more prevalent DCs at baseline that showed no consistent change with treatment. Therefore, IFN-α can induce DC differentiation from CML progenitor cells both in vitro and in vivo. The therapeutic activity of IFN-α in CML may be due to its ability to stimulate the generation of DCs that can present CML-specific antigens. Resistance to IFN-α may result when DC differentiation becomes impaired.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  1. Sawyers CL . Chronic myeloid leukemia N Engl J Med 1999 340: 1330–1340

    Article  CAS  PubMed  Google Scholar 

  2. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU . Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Ann Intern Med 1991 114: 532–538

    Article  CAS  PubMed  Google Scholar 

  3. Ozer H, George SL, Schiffer CA, Rao K, Rao N, Wurster-Hill DH, Arthur DD, Powell B, Gottlieb A, Peterson BA, Rai K, Testa JR, LeBeau M, Tantravahi R, Bloomfield CD . Prolonged subcutaneous administration of recombinant α2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B Study 8583 Blood 1993 82: 2975–2984

    CAS  PubMed  Google Scholar 

  4. Katz SI, Tamaki K, Sachs DH . Epidermal Langerhans cells are derived from cells originating in bone marrow Nature 1986 282: 324–327

    Article  Google Scholar 

  5. Bowers WE, Berkowitz M . Differentiation of dendritic cells in cultures of rat bone marrow cells J Exp Med 1979 163: 872–883

    Article  Google Scholar 

  6. O'Doherty U, Steinman RM, Peng M et al. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium J Exp Med 1993 178: 1067

    Article  CAS  PubMed  Google Scholar 

  7. Sallusto F, Lanzavecchia A . Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α J Exp Med 1994 179: 1109–1118

    Article  CAS  PubMed  Google Scholar 

  8. Romani N, Gruner S, Brang D, Kämpgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G . Proliferating dendritic cell progenitors in peripheral blood J Exp Med 1994 180: 83–93

    Article  CAS  PubMed  Google Scholar 

  9. Kiertscher SM, Roth M . Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4 J Leukoc Biol 1996 59: 208–218

    Article  CAS  PubMed  Google Scholar 

  10. Choudhury A, Gajewski JL, Liang JC, Popat U, Claxton DF, Kliche K-O, Andreeff M, Champlin RE . Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia Blood 1997 89: 1133–1142

    CAS  PubMed  Google Scholar 

  11. Smit WM, Rijnbeek M ., van Bergen CAM, de Paus RA, Vervenne HAW, van de Keur M, Willemze R, Falkenburg JHF. Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells Hum Immunol 1997 53: 216–223

    Article  CAS  PubMed  Google Scholar 

  12. Eibl B, Ebner S, Duba C, Böck G, Romani N, Erdel M, Gächter A, Niederwieser D, Schuler G . Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response Genes Chromosomes Cancer 1997 20: 215–223

    Article  CAS  PubMed  Google Scholar 

  13. Coleman S, Throp D, Fisher J, Bailey-Wood R, Lim SH . Cytokine enhancement of immunogenicity in chronic myeloid leukaemia Leukemia 1997 11: 2055–2059

    Article  CAS  PubMed  Google Scholar 

  14. Wang C, Al-Omar HM, Radvanyi L, Banerjee A, Bouman D, Squire J, Messner HA . Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of the T-cells stimulatory activity by IFN-α Exp Hematol 1999 27: 1176–1184

    Article  CAS  PubMed  Google Scholar 

  15. Heinzinger M, Waller CF, von den Berg A, Rosenstiel A, Lange W . Generation of dendritic cells from patients with chronic myelogenous leukemia Ann Hematol 1999 78: 181–186

    Article  CAS  PubMed  Google Scholar 

  16. Lim SH, Coleman S, Bailey-Wood R . In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia Bone Marrow Transplant 1998 22: 1185–1190

    Article  CAS  PubMed  Google Scholar 

  17. Fujii S-I, Shimizu K, Fujimoto K, Kiyokawa T, Shimomura T, Taniguchi O, Kinoshita M, Kawano F . Analysis of a chronic myelogenous leukemia patient vaccinated with leukemic dendritic cells following autologous peripheral blood stem cell transplantation Jpn J Cancer Res 1999 90: 1117–1129

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Claxton DF, McMannis J, Delima M, Champlin R, Choudhury A . Generation and clinical use of leukemia derived dendritic cell activated lymphocytes in patients with chronic myelogenous leukemia Blood 2000 96: 145a

    Google Scholar 

  19. Paquette RL, Hsu NC, Kiertscher SM, Park AN, Tran L, Roth MD, Glaspy J . Interferon-α and granulocyte/macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells J Leukoc Biol 1998 64: 358–367

    Article  CAS  PubMed  Google Scholar 

  20. Yamashiro-Matsumura S, Matsumura F . Intracellular localization of the 55-kD actin-bundling protein in cultured cells: spatial relationships with actin, a-actinin, tropomyosin, and fimbrin J Biol Chem 1986 103: 631–640

    CAS  Google Scholar 

  21. Pinkus GS, Pinkus JL, Langhoff E, Matsumura F, Yamashiro S, Mosialos G, Said JW . Fascin, a sensitive new marker for Reed–Sternberg cells of Hodgkin's disease Am J Pathol 1997 150: 543–562

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research was supported by grants from the Leukemia and Lymphoma Society of America, the UCLA Jonsson Cancer Center Foundation and the University of California Cancer Research Coordinating Committee. Additional support came from the Perry Cohan Fund.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paquette, R., Hsu, N., Said, J. et al. Interferon-α induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo. Leukemia 16, 1484–1489 (2002). https://doi.org/10.1038/sj.leu.2402602

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402602

Keywords

This article is cited by

Search

Quick links